OTC - ACTIVE INGREDIENT SECTION
Active Ingredient Purpose
Menthol (0.05%) Topical Analgesic
No Pain More Gain
- Manufacturer
- Lugus Group LLC
- Effective date
- 2019-12-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 17
- Source
- full-release
- Hydrated at
- 2026-05-31 23:02:04
Label at a glance#
ProductNo Pain More Gain
Active ingredientMENTHOL
Label structure10 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Use
For temporary relief of muscle and joint pain associated with arthritis, backaches, strains, sports injuries, muscle stiffness
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
Directions
Shake Well. Adults and children of 2 years and older apply to the affected areas up to 4 times a day. Massage in gently.
WARNINGS SECTION
Warnings
• For external use only • Avoid contact with the eyes and mucous membranes • Do not use with a heating pad • Do not use on open wounds or broken skin.
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Benzyl Benzoate, Butane, Caprylyl Glycol, Cetyl Alcohol, Citral, Citronellol, Cocamidopropyl Betaine, Geraniol, Glycerin, Hydroxycitronellal, Limonene, Linalool, Panthenol, Parfum, Polyacrylate Crosspolymer-6, Propane, Silica, Sodium Hyaluronate, Stearic Acid, Water.
OTHER SAFETY INFORMATION
Other Information
Contents under pressure. Do not expose to sunlight or keep where temperatures exceed 120°F. Do not spray into flames or hot surfaces. Keep away from sources of ignition. Do not puncture or incinerate container. When using this product, keep away from face and mouth to avoid breathing in.
INDICATIONS & USAGE SECTION
100% Vegan
No Pain More Gain Foam
Moisturizing Pain Relief
NPMG is • 100% vegan • Gluten-free • Free of paraben, paraffin and silicone oil • Made from spring water • Not tested on animals
For pain treatment and as preventive measure on sensitive areas. NPMG provides temporary but long lasting pain relief and moisturizes the skin. The natural alternative with the advanced German formula starts to work on contact. NPMG penetrates deeply, absorbs quickly and has a fresh and pleasant scent.
NPMG Foam is a product of
Lugus Group LLC, Buffalo, WY 82834
NET WT 2.5 fl oz (75 ml)
OTC - STOP USE SECTION
Stop use and ask a doctor if
• Condition worsens • skin irritation occurs • Symptoms persist for more than 7 days or clear up and occur again within a few days
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69161-002-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3ee5-a910-e053-dadaa90a0b85 | ff9c9a10-7780-4c29-a623-f04df2ba6785 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69161-002-01 | No Pain More Gain | 75 mg in 1 PACKAGE | AEROSOL, FOAM | 75 | 17 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 3 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 3 | |
| .BETA.-CITRONELLOL, (R)- | INACTIVE INGREDIENT | P01OUT964K | 3 | |
| BENZYL BENZOATE | INACTIVE INGREDIENT | N863NB338G | 3 | |
| BUTANE | INACTIVE INGREDIENT | 6LV4FOR43R | 3 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 3 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 3 | |
| CITRAL | INACTIVE INGREDIENT | T7EU0O9VPP | 3 | |
| COCAMIDOPROPYL BETAINE | INACTIVE INGREDIENT | 5OCF3O11KX | 3 | |
| GERANIOL | INACTIVE INGREDIENT | L837108USY | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 3 | |
| HYDROXYCITRONELLAL | INACTIVE INGREDIENT | 8SQ0VA4YUR | 3 | |
| LIMONENE, (+)- | INACTIVE INGREDIENT | GFD7C86Q1W | 3 | |
| LINALOOL, (+)- | INACTIVE INGREDIENT | F4VNO44C09 | 3 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 3 | |
| PROPANE | INACTIVE INGREDIENT | T75W9911L6 | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 3 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Products#
Every source-derived product name is available through these pages.
- No Pain More Gain
- Menthol
- BUTANE
- WATER
- GLYCERIN
- PROPANE
- CETYL ALCOHOL
- PANTHENOL
- HYALURONATE SODIUM
- STEARIC ACID
- CAPRYLYL GLYCOL
- SILICON DIOXIDE
- COCAMIDOPROPYL BETAINE
- BENZYL BENZOATE
- CITRAL
- .BETA.-CITRONELLOL, (R)-
- GERANIOL
- HYDROXYCITRONELLAL
- LIMONENE, (+)-
- LINALOOL, (+)-
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69161-002 | 69161-002-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BUTANE | 6LV4FOR43R | IACT |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| PROPANE | T75W9911L6 | IACT |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| PANTHENOL | WV9CM0O67Z | IACT |
| HYALURONATE SODIUM | YSE9PPT4TH | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| CAPRYLYL GLYCOL | 00YIU5438U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| COCAMIDOPROPYL BETAINE | 5OCF3O11KX | IACT |
| BENZYL BENZOATE | N863NB338G | IACT |
| CITRAL | T7EU0O9VPP | IACT |
| .BETA.-CITRONELLOL, (R)- | P01OUT964K | IACT |
| GERANIOL | L837108USY | IACT |
| HYDROXYCITRONELLAL | 8SQ0VA4YUR | IACT |
| LIMONENE, (+)- | GFD7C86Q1W | IACT |
| LINALOOL, (+)- | F4VNO44C09 | IACT |
| MENTHOL | L7T10EIP3A | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| BENZYL BENZOATE | BENZYL BENZOATE | N863NB338G | SOLUTION / INTRAMUSCULAR | 447 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | EMULSION / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SOLUTION / ORAL | 1.8 mg/120ml | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED / ORAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, COATED / ORAL | 0.25 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / VAGINAL | 0.75 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / TOPICAL | 2.01 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | 35 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CREAM / VAGINAL | 200 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 99eb178d-22e8-646c-e053-2995a90a8706 | ff9c9a10-7780-4c29-a623-f04df2ba6785 | 2019-12-17 | Warnings | 99eb178d-22e8-646c-e053-2995a90a8706 ff9c9a10-7780-4c29-a623-f04df2ba6785 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.